benzonatate

Product NDC
53002-0412
Requested package NDC
53002-0412-1
11-digit product format
530020412
Labeler code
53002
Product ID
53002-0412_daa38471-991b-43e3-8a25-c041105261e4
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
benzonatate
Dosage form
CAPSULE
Route
ORAL
Labeler
RPK Pharmaceuticals, Inc.
Application
ANDA040749
Marketing category
ANDA
Marketing start
2017-03-22
Marketing end
0000-00-00
Substance
BENZONATATE
Active strength
200 mg/1
Pharmacologic classes
Decreased Tracheobronchial Stretch Receptor Activity [PE],Non-narcotic Antitussive [EPC]
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage53002-041253002-0412-1IInactivated by FDA2026-07-31

Source provenance: Browse the complete Orange Book source catalog.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
benzonatateBENZONATATEBryant Ranch Prepacka788cb01-6dc3-4f28-aaa0-c23ac058c39a2026-05-28Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040749
application number: ANDA040749
benzonatateBENZONATATEProficient Rx LP9566b9b9-54ef-423c-8ce4-0f17140521582022-05-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040749
application number: ANDA040749
benzonatateBENZONATATEProficient Rx LP27156dad-64d6-4ea4-a3da-29e8e096fb012020-01-01Warnings, Adverse reactionsExact identifier
application applno (ANDA): 040749
application number: ANDA040749

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dc429dc2-e942-6686-8d72-b63c57e806aaProduct name520190416
d45c2ed6-126c-dd22-afd2-e29a2ecf77b9Product name320190215

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
53002-0412-12025-01-30C16284748780-1f386c649-d2ec-0266-e053-dadaa90a7c1aBenzonatate Capsules, USP 100 mg, 150 mg and 200 mg
53002-0412-22025-01-30C16284748780-1f386c649-d2ec-0266-e053-dadaa90a7c1aBenzonatate Capsules, USP 100 mg, 150 mg and 200 mg
53002-0412-32025-01-30C16284748780-1f386c649-d2ec-0266-e053-dadaa90a7c1aBenzonatate Capsules, USP 100 mg, 150 mg and 200 mg
53002-0412-42025-01-30C16284748780-1f386c649-d2ec-0266-e053-dadaa90a7c1aBenzonatate Capsules, USP 100 mg, 150 mg and 200 mg
53002-0412-12023-06-07C16284748780-1f386c649-d2ec-0266-e053-dadaa90a7c1aBenzonatate Capsules, USP 100 mg, 150 mg and 200 mg
53002-0412-22023-06-07C16284748780-1f386c649-d2ec-0266-e053-dadaa90a7c1aBenzonatate Capsules, USP 100 mg, 150 mg and 200 mg
53002-0412-32023-06-07C16284748780-1f386c649-d2ec-0266-e053-dadaa90a7c1aBenzonatate Capsules, USP 100 mg, 150 mg and 200 mg
53002-0412-42023-06-07C16284748780-1f386c649-d2ec-0266-e053-dadaa90a7c1aBenzonatate Capsules, USP 100 mg, 150 mg and 200 mg
53002-0412-12023-01-30C16284748780-1f386c649-d2ec-0266-e053-dadaa90a7c1aBenzonatate Capsules, USP 100 mg, 150 mg and 200 mg
53002-0412-22023-01-30C16284748780-1f386c649-d2ec-0266-e053-dadaa90a7c1aBenzonatate Capsules, USP 100 mg, 150 mg and 200 mg
53002-0412-32023-01-30C16284748780-1f386c649-d2ec-0266-e053-dadaa90a7c1aBenzonatate Capsules, USP 100 mg, 150 mg and 200 mg
53002-0412-42023-01-30C16284748780-1f386c649-d2ec-0266-e053-dadaa90a7c1aBenzonatate Capsules, USP 100 mg, 150 mg and 200 mg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53002-0412-1benzonatate10 in 1 BOTTLECAPSULE106
53002-0412-2benzonatate15 in 1 BOTTLECAPSULE156
53002-0412-3benzonatate20 in 1 BOTTLECAPSULE206
53002-0412-4benzonatate30 in 1 BOTTLECAPSULE306

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53002-0412BENZONATATE CAPSULE [RPK PHARMACEUTICALS, INC.]6Legacy NDC, 4 package rows20230609_9e1a2e84-c27a-4cb6-addb-cbe5d4b7d70e.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
283417benzonatate 200 MG Oral CapsulePSN9e1a2e84-c27a-4cb6-addb-cbe5d4b7d70e6
283417benzonatate 200 MG Oral CapsuleSCD9e1a2e84-c27a-4cb6-addb-cbe5d4b7d70e6

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
53002-0412-15300204120110 CAPSULE in 1 BOTTLE (53002-0412-1) 10 capsule2019-01-010000-00-00NoNoCurrent